UnitedHealth Group Incorporated (NYSE:UNH) is Handelsbanken Fonder AB’s 9th Largest Position

Handelsbanken Fonder AB decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 876,348 shares of the healthcare conglomerate’s stock after selling 323 shares during the quarter. UnitedHealth Group makes up 1.7% of Handelsbanken Fonder AB’s holdings, making the stock its 9th largest holding. Handelsbanken Fonder AB owned 0.10% of UnitedHealth Group worth $443,309,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. WealthBridge Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 1.2% during the 4th quarter. WealthBridge Capital Management LLC now owns 1,965 shares of the healthcare conglomerate’s stock valued at $994,000 after purchasing an additional 23 shares during the last quarter. Sunpointe LLC increased its stake in UnitedHealth Group by 6.5% in the 4th quarter. Sunpointe LLC now owns 2,930 shares of the healthcare conglomerate’s stock worth $1,482,000 after acquiring an additional 179 shares during the last quarter. Parthenon LLC boosted its position in shares of UnitedHealth Group by 12.3% during the 4th quarter. Parthenon LLC now owns 546 shares of the healthcare conglomerate’s stock valued at $276,000 after acquiring an additional 60 shares during the last quarter. Financial Perspectives Inc increased its position in UnitedHealth Group by 7.2% in the fourth quarter. Financial Perspectives Inc now owns 4,459 shares of the healthcare conglomerate’s stock worth $2,256,000 after purchasing an additional 300 shares during the last quarter. Finally, Alberta Investment Management Corp lifted its position in UnitedHealth Group by 211.4% during the fourth quarter. Alberta Investment Management Corp now owns 24,915 shares of the healthcare conglomerate’s stock valued at $12,604,000 after purchasing an additional 16,915 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.33% of the stock is owned by insiders.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $510.75 on Thursday. The firm has a market capitalization of $470.03 billion, a P/E ratio of 32.95, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a 50 day moving average price of $520.62 and a 200 day moving average price of $561.67.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the firm earned $5.83 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.